Atai Life Sciences N.V.

NasdaqGM:ATAI Stock Report

Market Cap: US$266.8m

Atai Life Sciences Management

Management criteria checks 3/4

Atai Life Sciences' CEO is Srini Rao, appointed in Jun 2024, has a tenure of less than a year. total yearly compensation is $1.73M, comprised of 31.7% salary and 68.3% bonuses, including company stock and options. directly owns 0.07% of the company’s shares, worth $185.80K. The average tenure of the management team and the board of directors is 1.1 years and 3.8 years respectively.

Key information

Srini Rao

Chief executive officer

US$1.7m

Total compensation

CEO salary percentage31.7%
CEO tenureless than a year
CEO ownership0.07%
Management average tenure1.1yrs
Board average tenure3.8yrs

Recent management updates

Recent updates

Psychedelic Stock Deep Dive: Atai Life Sciences

Sep 03

Is Atai Life Sciences (NASDAQ:ATAI) Using Debt In A Risky Way?

Jul 15
Is Atai Life Sciences (NASDAQ:ATAI) Using Debt In A Risky Way?

ATAI: Enormous Potential Upside But No Clarity Yet

May 27

Is Atai Life Sciences (NASDAQ:ATAI) Using Debt Sensibly?

Mar 02
Is Atai Life Sciences (NASDAQ:ATAI) Using Debt Sensibly?

atai Life Sciences achieves positive results in phase 1 trial of kratom-derived drug

Oct 12

Atai Life Sciences: Decentralized Drug Discovery Platform

Oct 06

ATAI Life Sciences GAAP EPS of -$0.24 misses by $0.01

Aug 15

We're Hopeful That Atai Life Sciences (NASDAQ:ATAI) Will Use Its Cash Wisely

Aug 07
We're Hopeful That Atai Life Sciences (NASDAQ:ATAI) Will Use Its Cash Wisely

Atai Life Sciences: Leading But Early Stage Psychedelic Therapeutics Developer

Jul 07

atai Life Sciences company Kures Therapeutics appoints Dr. Chad Beyer as CEO

Jun 30

Atai Life Sciences N.V.: A First Take

Jun 02

Atai Life Sciences And The Future Of Psychedelics For Mental Health

May 27

We're Hopeful That Atai Life Sciences (NASDAQ:ATAI) Will Use Its Cash Wisely

Apr 22
We're Hopeful That Atai Life Sciences (NASDAQ:ATAI) Will Use Its Cash Wisely

CEO Compensation Analysis

How has Srini Rao's remuneration changed compared to Atai Life Sciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$129m

Jun 30 2024n/an/a

-US$58m

Mar 31 2024n/an/a

-US$34m

Dec 31 2023US$2mUS$550k

-US$40m

Sep 30 2023n/an/a

-US$67m

Jun 30 2023n/an/a

-US$145m

Mar 31 2023n/an/a

-US$149m

Dec 31 2022US$4mUS$550k

-US$152m

Sep 30 2022n/an/a

-US$196m

Jun 30 2022n/an/a

-US$194m

Mar 31 2022n/an/a

-US$205m

Dec 31 2021US$12mUS$481k

-US$168m

Sep 30 2021n/an/a

-US$166m

Jun 30 2021n/an/a

-US$218m

Mar 31 2021n/an/a

-US$185m

Dec 31 2020US$3mUS$400k

-US$170m

Compensation vs Market: Srini's total compensation ($USD1.73M) is about average for companies of similar size in the US market ($USD1.46M).

Compensation vs Earnings: Srini's compensation has been consistent with company performance over the past year.


CEO

Srini Rao (55 yo)

less than a year

Tenure

US$1,734,650

Compensation

Dr. Srinivas G. Rao, M.D., Ph D., also known as Srini, serves as Co-Chief Executive Officer of Atai Life Sciences N.V. since June 01, 2024. He serves as Clinical Advisory Board Member at Bionomics Limited...


Leadership Team

NamePositionTenureCompensationOwnership
Christian Angermayer
Founder & Chairman of the Supervisory Boardno dataUS$158.96k2.48%
$ 6.6m
Srinivas Rao
Co-Founder & Co-CEOless than a yearUS$1.73m0.070%
$ 185.8k
Florian Brand
Co-Founder6.4yrsUS$3.03m0.20%
$ 526.3k
Anne Johnson
Chief Financial Officer1.1yrsUS$1.17m0.044%
$ 117.0k
Michael Raven
Senior Vice President of Operations1.1yrsno datano data
Frank Stegert
Vice President of Investment & Venture Management3.8yrsno datano data
Ryan Barrett
Senior VP3.8yrsno datano data
Glenn Short
Senior Vice President of Early Development1.1yrsno datano data
Sahil Kirpekar
Chief Business Officer2yrsno data0.038%
$ 102.1k
Kevin Craig
Senior Vice President of Clinical Development1.1yrsno datano data

1.1yrs

Average Tenure

43yo

Average Age

Experienced Management: ATAI's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Christian Angermayer
Founder & Chairman of the Supervisory Board3.8yrsUS$158.96k2.48%
$ 6.6m
Sabrina Johnson
Independent Member of Supervisory Board3.8yrsUS$151.96k0%
$ 0
Laurent Fischer
Independent Supervisory Directorless than a yearno datano data
Amir Kalali
Independent Member of Supervisory Board3.8yrsUS$140.46k0.0028%
$ 7.4k
Scott Braunstein
Independent Supervisory Directorless than a yearno datano data
Andrea Smiley
Independent Member of Supervisory Board3.8yrsUS$150.46k0.0028%
$ 7.4k
Michael B. Auerbach
Independent Lead Member of Supervisory Board3.8yrsUS$158.96k0.31%
$ 833.6k

3.8yrs

Average Tenure

57yo

Average Age

Experienced Board: ATAI's board of directors are considered experienced (3.8 years average tenure).